Compare Aurora Cannabis Inc (ACB) vs ZIM Integrated Shipping Services Ltd (ZIM) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

ZIM trades at $23.71, down 7.27% over 24 hours amid bearish technical signals and regulatory uncertainty around its proposed merger with Hapag-Lloyd. The company reported a Q1 2026 net loss of $86 million, missing EPS expectations, with revenue declining to $1.40 billion. Valuation metrics show a P/E of 28.91 and P/S of 0.45, while analyst sentiment is divided with a consensus price target of $16.75.

The outlook is clouded by merger risks and volatile freight rates, but the stock trades below book value, offering potential upside if the deal proceeds or asset value is realized. Key risks include regulatory hurdles and earnings volatility, requiring careful monitoring of merger developments and quarterly results.